Both in Pharmaceuticals
Genelux vs Perspective Therapeutics
Over the past year GNLX returned −75.8% and CATX returned −62.7%; their daily moves had a correlation of 0.23.
GNLX −75.8% CATX −62.7%Growth of $1, one year, split-adjusted
| Metric | GNLX | CATX |
|---|---|---|
| Price | $1.96 | $0.8702 |
| Market cap | $88.7M | $99.3M |
| Today | +2.08% | −1.11% |
| 1 month | −22.8% | −63.1% |
| 6 months | −31.7% | −77.2% |
| Year to date | −55.0% | −68.4% |
| 1 year | −76.2% | −66.5% |
| Revenue growth (YoY) | — | −72.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −33069.1% |
| P/E (TTM) | — | — |
| Price / sales | 11,085.1× | 242.9× |
| Net cash | $18.7M | $235.3M |
| Dividend yield | — | — |
| Volatility (60d) | 65.8% | 117.1% |
| Short % of float | 12.9% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).